HROW241220P35000
- 1.45
- 0.000.00%
Harrow Newsroom
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Lake Street Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $55
Harrow Health's Strategic Transformation and Growth Potential Underscore Buy Rating
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $73
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Lake Street Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $55
Lake Street Releases a Buy Rating on Harrow Health (HROW)
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $73
B.Riley Financial Maintains Harrow(HROW.US) With Buy Rating, Raises Target Price to $73
B. Riley Adjusts Price Target on Harrow to $73 From $50, Maintains Buy Rating
Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating
Harrow Is Maintained at Buy by Lake Street
Harrow Analyst Ratings